Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA; Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Bioorg Med Chem Lett. 2023 Jul 15;91:129364. doi: 10.1016/j.bmcl.2023.129364. Epub 2023 Jun 7.
Hydrogen-tritium exchange is widely employed for radioisotopic labeling of molecules of biological interest but typically involves the metal-promoted exchange of sp-hybridized carbon-hydrogen bonds, a strategy that is not directly applicable to the antibiotic iboxamycin, which possesses no such bonds. We show that ruthenium-induced 2'-epimerization of 2'-epi-iboxamycin in HTO (200 mCi) of low specific activity (10 Ci/g, 180 mCi/mmol) at 80 °C for 18 h affords after purification tritium-labeled iboxamycin (3.55 µCi) with a specific activity of 53 mCi/mmol. Iboxamycin displayed an apparent inhibition constant (K) of 41 ± 30 nM towards Escherichia coli ribosomes, binding approximately 70-fold more tightly than the antibiotic clindamycin (K = 2.7 ± 1.1 µM).
氚-氢交换被广泛应用于生物感兴趣分子的放射性同位素标记,但通常涉及金属促进的 sp 杂化碳氢键的交换,这种策略不适用于抗生素伊博霉素,因为它没有这样的键。我们表明,在 80°C 下,用低比活度(10 Ci/g,180 mCi/mmol)的 HTO(200 mCi)对 2'-epi-伊博霉素进行钌诱导的 2'-差向异构化反应 18 小时后,经纯化可得到具有 53 mCi/mmol 的比活度的氚标记伊博霉素(3.55 µCi)。伊博霉素对大肠杆菌核糖体的表观抑制常数(K)为 41±30 nM,其结合亲和力比抗生素克林霉素(K=2.7±1.1 µM)高约 70 倍。